Risk of recurrent myocardial infarction with the concomitant use of clopidogrel and proton pump inhibitors

Abstract

The apparent association between recurrent MI and use of PPIs with clopidogrel depends on the design, and is affected by confounding by indication. The association is not present when (un)measured confounding is addressed by design.